当前位置：
X-MOL 学术
›
Lancet Psychiatry
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Disparate regulatory status of methylphenidate for adults with ADHD across Europe.
The Lancet Psychiatry ( IF 30.8 ) Pub Date : 2020-01-01 , DOI: 10.1016/s2215-0366(19)30482-1 Mathieu Chappuy 1 , Antoine Boulanger 2 , Mikail Nourredine 2 , Pierre Fourneret 3 , Benjamin Rolland 4
The Lancet Psychiatry ( IF 30.8 ) Pub Date : 2020-01-01 , DOI: 10.1016/s2215-0366(19)30482-1 Mathieu Chappuy 1 , Antoine Boulanger 2 , Mikail Nourredine 2 , Pierre Fourneret 3 , Benjamin Rolland 4
Affiliation
|
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that typically occurs between 6 years and 12 years of age that affects between 2% and 7% of school-age children and between 2% and 3% of the adult population. Although ADHD was thought to progressively disappear during adolescence, evidence suggests that ADHD can persist or possibly even occur in adulthood. Methylphenidate is the most common first-line medication for children with ADHD and efficacy has also been found in adults. Treatment guidelines in adults with ADHD usually recommend the prescription of the methylphenidate if it was not used in childhood, provided that ADHD symptoms induce important functional impairments.
中文翻译：
在欧洲，哌醋甲酯对患有ADHD的成年人的监管状况不同。
注意缺陷多动障碍（ADHD）是一种神经发育障碍，通常发生在6岁至12岁之间，影响2％至7％的学龄儿童和2％至3％的成年人口。尽管人们认为多动症在青春期会逐渐消失，但有证据表明多动症可以持续甚至在成年期发生。哌醋甲酯是多动症儿童最常见的一线药物，并且在成人中也发现了疗效。如果ADHD症状引起重要的功能障碍，则在儿童期未使用的成人多动症患者的治疗指南通常建议使用哌醋甲酯处方。
更新日期：2019-12-19
中文翻译：
在欧洲，哌醋甲酯对患有ADHD的成年人的监管状况不同。
注意缺陷多动障碍（ADHD）是一种神经发育障碍，通常发生在6岁至12岁之间，影响2％至7％的学龄儿童和2％至3％的成年人口。尽管人们认为多动症在青春期会逐渐消失，但有证据表明多动症可以持续甚至在成年期发生。哌醋甲酯是多动症儿童最常见的一线药物，并且在成人中也发现了疗效。如果ADHD症状引起重要的功能障碍，则在儿童期未使用的成人多动症患者的治疗指南通常建议使用哌醋甲酯处方。
京公网安备 11010802027423号